NASDAQ:CRBU - Nasdaq - US1420381089 - Common Stock - Currency: USD
TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 11.47M | 34.48M | 13.85M | 9.60M | 12.36M | |||
Operating Expenses | 176.66M | 150.54M | 120.25M | 76.57M | 48.49M | |||
Research and Development | 130.97M | 112.08M | 82.23M | 52.26M | 34.43M | |||
Selling, General, and Administrative Expenses | 45.69M | 38.46M | 38.02M | 24.32M | 14.06M | |||
Operating Income | -165.18M | -116.06M | -106.40M | -66.98M | -36.12M | |||
Interest Income/Expense | -125.00K | -6.00K | -130.00K | 140.00K | -520.00K | |||
Other Income/Expense | 17.38M | 14.19M | 7.18M | -1.35M | 510.00K | |||
Non Recurring Items | N/A | N/A | 0.00 | 1.58M | N/A | |||
Income Before Taxes | -147.93M | -101.88M | -99.35M | -66.60M | -36.13M | |||
Income Tax | N/A | 193.00K | 70.00K | 320.00K | -1.82M | |||
Net Income | -148.12M | -102.07M | -99.42M | -66.92M | -34.31M | |||
EBITDA | -161.71M | -112.53M | -104.78M | -66.00M | -35.22M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -1.65 | -1.38 | -1.64 | -1.11 | -0.60 | |||
Non GAAP EPS | -1.65 | -1.45 | -1.64 | N/A | N/A | |||
Statistics | ||||||||
Profit Margin | -1290.81% | -296.05% | -717.83% | -697.08% | -277.59% | |||
Operating Profit Margin | -1439.50% | -336.63% | -768.23% | -697.71% | -292.23% |
All data in USD